Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema

Saved in:
Bibliographic Details
Published inJournal of investigational allergology & clinical immunology Vol. 21; no. 5; pp. 416 - 417
Main Authors Ramírez del Pozo, M E, Contreras Contreras, E, López Tiro, J, Gómez Vera, J
Format Journal Article
LanguageEnglish
Published Spain 2011
Subjects
Adolescent
Adult
Antibodies, Anti-Idiotypic - administration & dosage
Antibodies, Anti-Idiotypic - adverse effects
Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized
Child
Dermatitis, Atopic - drug therapy
Dermatitis, Atopic - immunology
Disease Progression
Female
Follow-Up Studies
Humans
Immunoglobulin E - blood
Immunoglobulin E - immunology
Male
Middle Aged
Omalizumab
Quality of Life
Severity of Illness Index
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1018-9068